American International Group’s SQZ Biotechnologies Company SQZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-2,517,173
Closed -$202K 3069
2023
Q3
$202K Hold
2,517,173
﹤0.01% 2114
2023
Q2
$680K Hold
2,517,173
﹤0.01% 1463
2023
Q1
$1.41M Hold
2,517,173
0.01% 1062
2022
Q4
$1.86M Hold
2,517,173
0.01% 964
2022
Q3
$5.74M Hold
2,517,173
0.04% 601
2022
Q2
$8.01M Sell
2,517,173
-11,304
-0.4% -$40.7K 0.05% 474
2022
Q1
$12.2M Sell
2,528,477
-795
-0% -$5.05K 0.07% 347
2021
Q4
$22.6M Sell
2,529,272
-361
-0% -$4.42K 0.11% 148
2021
Q3
$36.5M Sell
2,529,633
-296
-0% -$4.01K 0.19% 80
2021
Q2
$36.6K Buy
2,529,929
+9,743
+0.4% +$127K 0.12% 133
2021
Q1
$34.5K Buy
2,520,186
+2,517,598
+97,280% +$51.1M 0.12% 129
2020
Q4
$75 Buy
+2,588
New +$66.1K ﹤0.01% 2796

American International Group's SQZ Position: Q4 2023 in Review

American International Group sold out of SQZ Biotechnologies Company (SQZ) in Q4 2023, closing a stake of 2,517,173 shares — an estimated $202K sold.

American International Group first reported a position in SQZ in Q4 2020 and held it in 12 quarters. The position peaked at $36.5M in Q3 2021. 0 funds tracked by Wall St. Rank hold SQZ as of Q4 2023.

  • American International Group reported no remaining SQZ Biotechnologies Company position as of Q4 2023 after selling out during the quarter.
  • American International Group sold 2,517,173 SQZ Biotechnologies Company shares in Q4 2023, an estimated $202K.
  • American International Group first reported a position in SQZ Biotechnologies Company in Q4 2020 and held it in 12 quarters.
  • American International Group's SQZ Biotechnologies Company position peaked at $36.5M in Q3 2021.
  • 0 funds tracked by Wall St. Rank held SQZ Biotechnologies Company as of Q4 2023.

Based on American International Group's 13F filing for Q4 2023, filed 13 Feb 2024.